Cannabis Law Report

JULY 8, 2021

The Company expects to finalize the agreement with the research institute and commence studies by Fall 2021. The intended purpose of these studies is to provide data that will feed into the cbdMD Therapeutics research pipeline. and are difficult to predict. cbdMD, Inc.

Research and Development 111

Research and Development Pets Cannabinoids eCommerce 111

Cannabis Law Report

AUGUST 4, 2021

The Core Business delivered strong organic growth 13 in H1 2021 (17% year-on-year) despite some of Eurofins’ businesses remaining affected by lockdowns during H1 2021. The Core Business delivered strong organic growth 13 in H1 2021 (17% year-on-year) despite some of Eurofins’ businesses remaining affected by lockdowns during H1 2021.

Business 105

Business Research and Development Environment Food 105

Cannabis Law Report

JUNE 1, 2021

Canopy Growth Reports Fourth Quarter and Fiscal Year 2021 Financial Results. Achieves 37% revenue growth in FY 2021 with strong double-digit growth across both cannabis and other consumer products businesses. Fourth Quarter Fiscal 2021 Financial Summary. (in Fiscal Year 2021 Financial Summary. (in Net revenue. 2,800) bps.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

APRIL 18, 2022

I can’t discuss this topic with you.”. It does not appear to be a public health or safety matter, but I’m speculating, because they didn’t issue a recall. However, licensed safety labs already tested samples of the on-hold products for the presence of solvents, Boquette said. The CRA “said it’s related to an investigation.

Safety 52

Safety Vaping Edibles THC 52

Cannabis Law Report

JUNE 25, 2021

24 June 2021. According to the federal government, the Cannabis Act’s three stated objectives are to (i) keep cannabis out of the hands of young people, (ii) keep profits out of the pockets of criminals, and (iii) protect public health and safety by allowing adults to access legal cannabis. Torkin Manes LLP. with the authors.

Cannabinoids 91

Cannabinoids Edibles Retail Cannabis 91

Cannabis Law Report

OCTOBER 21, 2021

adults shows broad support for securely labeling cannabis products to verify their legitimacy and safety in the marketplace. Ensuring the safety of cannabis products is top of mind for Americans. Survey Method. About The Harris Poll .

Safety 52

Safety Research and Development Compliance Compliance 52

Cannabis Law Report

AUGUST 3, 2021

million in 2020, which now triples HempFusion’s historical proforma revenue to ~$12 million with significant expansion planned for 2021 and beyond, making it immediately accretive to the Company. Further, the Company announces that Ian deQueiroz has resigned as a director of the Company effective July 30, 2021.

Research and Development 105

Research and Development Topical Events Compliance 105

Canna Law Blog

DECEMBER 16, 2021

On Monday, November 13, 2021, New York Assemblyman Pat Burke introduced medical psilocybin legislation. Psilocybin research license, which will allow the testing potency, conducting clinical investigations, researching efficacy and safety, and agricultural research. A few key points from the bill: Several License Types.

Legislation 96

Legislation Treatment Therapy Conditions 96

Veriheal

AUGUST 3, 2021

Mainly, the measure protects patient safety and amplifies product quality requirements, all the while entrusting the state’s Medical Marijuana Advisory Board to consider broadening the program’s list of qualifying medical conditions. million in recorded sales revenue from April 2020 to March 2021.

Legislation 98

Legislation Patients Supply Chain Dispensary 98

Cannabis Law Report

AUGUST 25, 2021

(“Sagely Naturals”), (together the “Acquisitions”) for fiscal 2021 and 2022. With the completion of the Acquisitions and inclusion of the pre-closing fiscal 2021 revenues of Apothecanna and Sagely Naturals, HempFusion expects to generate revenues of between USD$12.5 million in revenue. million and $13.5 million and $13.5

Retail 111

Retail Supply Chain Research and Development Events 111

Cannabis Law Report

MAY 29, 2022

In May 2021, a Nature Medicine study showed the benefits of MDMA in relieving post-traumatic stress disorder. [4] 4] In April 2021, a separate study from the New England Journal of Medicine demonstrated the efficacy of psilocybin in reducing symptoms of depression. [5]

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JANUARY 12, 2022

In accordance with FDA requirements, an independent panel of qualified experts reviewed HempFusion’s safety dossier on its hemp-derived CBD extract, which included safety and toxicology studies, the published results of these studies, and a comprehensive review of the scientific literature on CBD. ABOUT HEMPFUSION.

Retail 52

Retail CBD Extraction Research and Development 52

The Cannigma

MAY 16, 2021

This data is particularly important for drivers, would-be drivers, policy makers, and anyone who is involved in carrying out or supervising safety sensitive tasks. Determining intoxication and impairment with cannabis is notoriously difficult and is nearly impossible to peg it to a per se limit of THC or its metabolites in the blood.

THC 145

THC Vaping Edibles CBD 145

Cannabis Law Report

AUGUST 27, 2021

per Common Share for a period of four years from the closing date of the Private Placement, expected on or about September 12, 2021. Each whole Warrant will entitle the holder to acquire one additional Common Share at a price of USD$0.50 HempFusion Wellness Inc. Follow HempFusion on Twitter , Facebook and Instagram.

Research and Development 105

Research and Development Events Hemp Food 105

TheAnswerPage

JANUARY 11, 2022

As a result, state medical marijuana rules and regulations have focused on the demands of the public without putting significant emphasis on the scientific data or the ability of the medical community to support and care for medical marijuana patients. Nov 24 2021. Journal of Clinical Gynecology and Obstetrics, North Amer, 0 Nov 2021.

Patients 98

Patients Education Marijuana Therapy 98

SpeedWeed

MARCH 19, 2021

After three full years of hemp cultivation, Linda Noel was confident 2021 would be a success. But Noel wouldn’t have grown hemp a fourth year if not for the MA Hemp Industry Survive and Thrive amendment included in the state’s 2021 fiscal budget. SEE MORE: 2020 Hemp Cultivation Data By State. where she also grows tomatoes. .

Hemp 52

Hemp Seed-To-Sale Dispensary Cultivation 52

Cannabis Law Report

NOVEMBER 2, 2021

Oracle wrote 21 October 2021. Testing for Safety: Are Impurities a Problem? Testing for Safety: Are Impurities a Problem? At present, with almost no regulation over the industry, there is a definite risk of what chemist and hemp safety expert Dr. Matthew Curran describes to Refinery29 as “kitchen chemistry.”

THC 96

THC CBD Legalization Vaping 96

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. in 2021 reached $2 billion, according to Statistica.)

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

AUGUST 6, 2021

Adjusted EBITDA loss in Q1 2022 was $64 million , a $29 million narrower loss versus Q1 2021 driven by higher sales and lower operating expenses. Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) today announces its financial results for the first quarter fiscal 2022 ended June 30, 2021.

Vaping 105

Vaping Research and Development Data Business 105

The Cannigma

JANUARY 13, 2023

Edibles won’t produce the same experience, but topicals may be able to help, too. The authors noted that while “promising data are emerging on the possible role of ECS in migraine…proper placebo-controlled trials are needed to establish a therapeutic role for cannabinoids.” Higher THC strains were also more commonly used for migraine.

Terpenes 132

Terpenes Strains THC Treatment 132

Healer

APRIL 5, 2021

Store aisles are stocked full of CBD oils, capsules, and tablets, topicals such as lotions, balms, salves and creams, vape pens, and hemp flower. Topical CBD for pain. CBD tinctures or oil drops can also be applied directly onto the skin as a topical or mixed with your own lotion for coverage over a greater area.

CBD 98

CBD Chronic Pain Oil Topical 98

The Cannigma

JULY 9, 2023

7 Despite concerns about cannabis and cognition, a 2021 review of the evidence found little connection between early cannabis use and negative effects on brain development. A 2022 systematic review and meta-analysis that reviewed data from approximately 5.5 16 Do edible and topical cannabis products stunt growth?

Research and Development 68

Research and Development THC Cannabinoids Topical 68

The Cannigma

OCTOBER 6, 2022

Cannabis use and pregnancy is a tough topic. Refusing to have a conversation around this topic only continues to fuel the stigma of cannabis use. CBD topicals may provide a better option for pregnant and breastfeeding women over Tylenol or other OTC pain medications. But most studies are done on THC and pregnancy – not CBD.

CBD 99

CBD Research and Development Topical THC 99

Healer

APRIL 5, 2021

Store aisles are stocked full of CBD oils, capsules, and tablets, topicals such as lotions, balms, salves and creams, vape pens, and hemp flower. Topical CBD for pain. CBD tinctures or oil drops can also be applied directly onto the skin as a topical or mixed with your own lotion for coverage over a greater area.

CBD 52

CBD Chronic Pain Oil Topical 52

Healer

APRIL 5, 2021

Store aisles are stocked full of CBD oils, capsules, and tablets, topicals such as lotions, balms, salves and creams, vape pens, and hemp flower. Topical CBD for pain. CBD tinctures or oil drops can also be applied directly onto the skin as a topical or mixed with your own lotion for coverage over a greater area.

CBD 52

CBD Chronic Pain Oil Topical 52

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

MAY 12, 2022

State policymakers and public lawyers now confront the challenge of developing licensing schemes and regulatory rules to protect public health and safety, designing effective tax rates and business structures, and advancing equitable goals ranging from expunging old convictions to helping disadvantaged communities participate in the industry.

Law 52

Law Policy State Laws Environment 52

Cannabis Law Report

NOVEMBER 10, 2021

as well as to support Good Laboratory Practices (GLP) toxicology, safety studies and preclinical efficacy studies. In October 2021, Virpax announced that a $1.87 Also, the NIH engaged Battelle to conduct Dose Range Finding Studies, with the first study in rats being completed on October 7 th , 2021. About Virpax Pharmaceuticals.

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

Cannabis Law Report

DECEMBER 6, 2021

The Department’s mission is to develop and implement progressive cannabis policies, while regulating commercial cannabis activity in a way that best protects public health, safety, the environment, and local communities throughout the State of California. Final Filing Date: 12/11/2021 Who May Apply. FREE PARKING!

Packaging 52

Packaging Environment Conditions Education 52

The Cannigma

DECEMBER 8, 2021

So, if anyone who knows NORML, probably not surprising that the main topic of this conversation was normalization of cannabis also legalization and something that I found really interesting about the interview with JM was digging into patient rights, and all of the work that NORML does around patient rights in the United States.

Access 81

Access Policy Patients Cannabis 81

Cannabis Law Report

JUNE 4, 2021

This list is focused on those who have had the largest impact for 2021. . Tim Ferriss is Psychedelics Invest’s number one most influential person for 2021 because of his support through his funding, utilization of his multiple massive social outlets, and his continued balanced message about the efficacy and realities of psychedelic medicines.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Canna Law Blog

OCTOBER 17, 2022

John presented incredibly interesting points and data, including the fact that most congressional candidates running in these mid-term elections hardly even mentioned the word marijuana when stumping. billion worth of marijuana sales in 2021. Oklahoma saw $150 million in revenue in 2021. percent of state tax revenue in 2021.”

Legalization 90

Legalization Banking Research and Development Policy 90

Cannabis Law Report

NOVEMBER 29, 2021

Medical marijuana has received more attention from legislators, scientists, researchers, clinicians, and the general public than any other topic. . Advocates claim that legalizing decreases crime rates, lowers criminal justice expenses, improves public health, generates tax revenue, enhances traffic safety, and promotes the economy. .

Legalization 52

Legalization Research and Development Decriminalization Marijuana 52

Cannabis Law Report

NOVEMBER 29, 2021

State legislators in 2021 enacted over 50 laws liberalizing marijuana policies in more than 25 states, according to a report issued today by the National Organization of the Reform of Marijuana Laws (NORML). 2021 was a significant year for marijuana policy reform. The law took effect on July 1, 2021. FULL REPORT. New Jersey.

Legislation 98

Legislation Patients Retail Access 98

Cannabis Law Report

MAY 14, 2022

Access to banking is a well-known issue for the cannabis industry and the repeated efforts to obtain the bill’s congressional passage over the past few years remains a hot topic for industry insiders and participants. MI – Michigan cannabis regulators axed a plan to allow hemp to be synthetically converted to THC. International.

Banking 52

Banking Recreational Research and Development Cannabis 52